Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avanos Medical Inc (AVNS)

Avanos Medical Inc (AVNS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,565,840
  • Shares Outstanding, K 47,929
  • Annual Sales, $ 652,300 K
  • Annual Income, $ 57,500 K
  • 60-Month Beta 1.56
  • Price/Sales 2.37
  • Price/Cash Flow 21.29
  • Price/Book 1.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.33
  • Number of Estimates 4
  • High Estimate 0.34
  • Low Estimate 0.31
  • Prior Year 0.33
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.29 +5.62%
on 11/15/19
48.07 -31.25%
on 11/04/19
-7.51 (-18.52%)
since 10/18/19
3-Month
31.29 +5.62%
on 11/15/19
48.07 -31.25%
on 11/04/19
-3.21 (-8.85%)
since 08/19/19
52-Week
31.29 +5.62%
on 11/15/19
53.45 -38.17%
on 02/26/19
-14.26 (-30.14%)
since 11/19/18

Most Recent Stories

More News
Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3

Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.

TMO : 306.42 (+1.80%)
RMD : 149.39 (+1.09%)
EW : 243.56 (+0.49%)
AVNS : 33.05 (+1.16%)
Avanos Medical (AVNS) Q3 Earnings and Revenues Lag Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 33.05 (+1.16%)
Avanos Medical (AVNS) Catches Eye: Stock Jumps 6.2%

Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

CMD : 72.35 (+1.46%)
AVNS : 33.05 (+1.16%)
AngioDynamics Boosts VIT Product Portfolio With New Buyout

AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.

ABMD : 184.34 (+3.51%)
ANGO : 15.21 (+0.80%)
ARAY : 2.75 (+2.23%)
AVNS : 33.05 (+1.16%)
Avanos Medical, Inc. to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt hotel in New York on Monday,...

MS : 49.33 (+0.61%)
AVNS : 33.05 (+1.16%)
New Strong Sell Stocks for August 19th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

ATHM : 71.05 (+0.16%)
CDK : 52.26 (+0.21%)
AIT : 62.49 (+1.18%)
CTRE : 20.50 (+0.05%)
AVNS : 33.05 (+1.16%)
Avanos (AVNS) Q2 Earnings Beat Estimates, Revenues Miss

Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.

ISRG : 577.80 (+1.53%)
SYK : 207.12 (+1.00%)
BAX : 81.67 (+0.68%)
AVNS : 33.05 (+1.16%)
Avanos Medical (AVNS) Tops Q2 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 33.05 (+1.16%)
Earnings Preview: Avanos Medical (AVNS) Q2 Earnings Expected to Decline

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVNS : 33.05 (+1.16%)
Avanos Medical Enters Oversold Territory (AVNS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

AVNS : 33.05 (+1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade AVNS with:

Business Summary

Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.

See More

Key Turning Points

2nd Resistance Point 33.97
1st Resistance Point 33.51
Last Price 33.05
1st Support Level 32.65
2nd Support Level 32.26

See More

52-Week High 53.45
Fibonacci 61.8% 44.98
Fibonacci 50% 42.37
Fibonacci 38.2% 39.76
Last Price 33.05
52-Week Low 31.29

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar